Form 8-K - Current report:
SEC Accession No. 0001564590-21-028386
Filing Date
2021-05-17
Accepted
2021-05-17 16:10:32
Documents
3
Period of Report
2021-05-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-8k_20210517.htm 8-K 29898
2 EX-99.1 rkda-ex991_6.htm EX-99.1 226007
3 GRAPHIC gl3eotb3p3c2000001.jpg GRAPHIC 3974
  Complete submission text file 0001564590-21-028386.txt   262670
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 21930639
SIC: 0100 Agricultural Production-Crops